Proteostasis Theraputics, Inc. ($PTI) is a Biotechnology company in the Healthcare sector. This stock is finally recovering after its waterfall on “Tuesday after results from a phase two trial of proprietary cystic fibrosis therapy showed that the mean absolute improvement in percent predicted forced expiratory volume in one second, or ppFEV1, lagged that of Vertex Pharmaceuticals’ (VTRX) triple-drug combination, trikafta.” It formed a nice descending wedge going into close last trading session, and I plan to day trade this over the $2.35 natural resistance level!
Cassava Sciences, Inc. ($SAVA) is a Biotechnology company in the Healthcare sector. This stock has been on the rise since the news released about some insider buying. “The Form 4 report issued Friday showed that director Sanford Robertson bought about 423,700 Cassava shares Friday, and about 76,000 shares Thursday, bringing his ownership to about 663,000 Cassava shares. The report also showed that Finance Chief Eric Schoen bought 5,300 shares Thursday.” I plan to day trade this over the $4.80 natural resistance level!